February 2014 HSCI Community Newsletter
The Harvard Stem Cell Matrix
Upcoming Events
Boston Single-Cell Network
Feb. 25, 4:30-6:00 PM

HSCI Blood Program Meeting
Mar. 7, 4:00PM-5:30PM
HSCI call for proposals:
P01 Pilot Grants 2014

Register to present a poster at the HSCI Annual Retreat in May

Book an appointment with Harvard iLab's Alice Ly to discuss health and life sciences entrepreneurship.
Research Technician II
Brack Lab - Massachusetts General Hospital CRM

Research Assistant
Camargo Lab - Boston Children's Hospital Stem Cell program
Media Mentions
Harvard Gazette
John Rinn, PhD, and Paola Arlotta, PhD, show lincRNAs are not genetic "junk" after all.

Al Jazeera TechKnow blog
Collaborators Amy Wagers, PhD, and Richard Lee, MD, talk about "what makes scientists tick."
Boston Globe highlights stem cell field's impact on biology
Paola Arlotta, PhD, Konrad Hochedlinger, PhD, and Richard Lee, MD, comment on what's been learned.

Earlier this week, the Boston Globe re-examined the promises of stem cell science. With input from three HSCI researchers, the article described how stem cells have made a radical impact on our understanding of cell biology, even if its treatment potential is still developing.

Said Richard Lee: "It's actually a really sort of spooky time, because there's this excitement and worry at the same time - excitement over the things we can do, but worry about how to do them and how to control them so that we can really make good on the promises."
Liver-pancreas cell fate switch
Wolfram Goessling, MD, PhD, and Trista North, PhD, discover new role for prostaglandin in development of liver and pancreas.

Harvard stem cell scientists have a new theory for how stem cells decide whether to become liver or pancreatic cells during development. A cell's fate, the researchers found, is determined by the nearby presence of prostaglandin E2, a messenger molecule best known for its role in inflammation and pain. The discovery, published in the journal Developmental Cell, could potentially make liver and pancreas cells easier to generate both in the lab and for future cell therapies. Continue reading

Lung repair coaxed by TSP-1
Carla Kim, PhD, reverses some lung diseases in mice by stimulating natural repair process with thrombospondin-1.


Reporting in Cell, Boston Children's Hospital researchers describe a new pathway in the lung, activated by injury, that directs stem cells to transform into specific types of cells. By enhancing this natural pathway in a mouse model, they successfully increased production of alveolar epithelial cells. These cells are irreversibly damaged in diseases like pulmonary fibrosis and emphysema. Read the whole story